SCHEMBL369230

SCHEMBL369230

Cc1cc(Cl)ccc1C(CC(=O)c1ccc(=O)n(C)c1)c1ccc(C(=O)NCC(O)CO)cc1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.35
TP53 P04637 2/20 0.35
POLB P06746 2/20 0.34
CREBBP Q92793 1/20 0.34
PRMT5 O14744 3/20 0.33
BRD4 O60885 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
EPHX2 P34913 1/20 0.33
GCG P01275 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
MEN1 O00255 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
F9 P00740 1/20 0.32
ACSS2 Q9NR19 2/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1390515 1.00 MAPK14 (0.35) MAPK14TP53POLBCREBBPPRMT5
SCHEMBL368689 0.91 MAPK14 (0.36) MAPK14TP53PRMT5BRD4GCG
SCHEMBL1390322 0.91 MAPK14 (0.36) MAPK14TP53PRMT5BRD4GCG
SCHEMBL369577 0.90 GPBAR1 (0.35) MAPK14TP53CREBBPPRMT5BRD4
SCHEMBL369578 0.90 GPBAR1 (0.35) MAPK14TP53CREBBPPRMT5BRD4
SCHEMBL369576 0.90 GPBAR1 (0.35) MAPK14TP53CREBBPPRMT5BRD4
SCHEMBL369579 0.90 GPBAR1 (0.35) MAPK14TP53CREBBPPRMT5BRD4
SCHEMBL368555 0.89 GCG (0.37) POLBCREBBPBRD4ALDH1A1HPGD
SCHEMBL1390288 0.88 BRD4 (0.38) MAPK14CREBBPPRMT5BRD4KDM4E
SCHEMBL1390287 0.88 BRD4 (0.38) MAPK14CREBBPPRMT5BRD4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 MAPK14 3679/4885TP53 4233/4885POLB 2940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.